Quarry LP Neurocrine Biosciences Inc Transaction History
Quarry LP
- $461 Billion
- Q1 2025
A detailed history of Quarry LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Quarry LP holds 500 shares of NBIX stock, worth $63,275. This represents 0.01% of its overall portfolio holdings.
Number of Shares
500
Previous 1,700
70.59%
Holding current value
$63,275
Previous $232 Million
76.17%
% of portfolio
0.01%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.1MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.8 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.26 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$700 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$615 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$338 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...